Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelika Caputo

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|December 7, 2007
Stratification for the propensity score compared with linear regression techniques to assess the effect of treatment or exposureStephen Senn, Erika Graf, Angelika Caputo
American Journal of Epidemiology|March 13, 2008
Evidence from nonrandomized studies: a case study on the estimation of causal effectsClaudia Schmoor, Angelika Caputo, Martin Schumacher
Social Science & Medicine (1982)|March 18, 2003
Undernutrition in Benin-an analysis based on graphical modelsAngelika Caputo, Ronja Foraita, Stephan Klasen, et al.
Journal of Clinical Psychopharmacology|June 4, 2010
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trialJohn Zajecka, Alan Schatzberg, Stephen Stahl, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trialStephen M Stahl, Maurizio Fava, Madhukar H Trivedi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2007
Clinical response by palpation during primary systemic therapy with four dose-dense cycles doxorubicin and docetaxel in patients with operable breast cancer: further results from a randomised controlled trialChristine Müller, Angelika Caputo, Martin Schumacher, et al.
Current Alzheimer Research|October 9, 2020
Modelling Decline in Cognition to Decline in Function in Alzheimer's DiseaseHelene Karcher, Marina Savelieva, Luyuan Qi, et al.
Alzheimer'S Research & Therapy|April 29, 2015
Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's diseaseMartin R Farlow, Niels Andreasen, Marie-Emmanuelle Riviere, et al.
Dementia and Geriatric Cognitive Disorders|July 17, 2012
Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's diseaseJeffrey Cummings, Lutz Froelich, Sandra E Black, et al.
Journal of the American College of Cardiology|November 7, 2006
Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placementWillibald Hochholzer, Dietmar Trenk, Hans-Peter Bestehorn, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|December 7, 2007
Stratification for the propensity score compared with linear regression techniques to assess the effect of treatment or exposureStephen Senn, Erika Graf, Angelika Caputo
American Journal of Epidemiology|March 13, 2008
Evidence from nonrandomized studies: a case study on the estimation of causal effectsClaudia Schmoor, Angelika Caputo, Martin Schumacher
Social Science & Medicine (1982)|March 18, 2003
Undernutrition in Benin-an analysis based on graphical modelsAngelika Caputo, Ronja Foraita, Stephan Klasen, et al.
Journal of Clinical Psychopharmacology|June 4, 2010
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trialJohn Zajecka, Alan Schatzberg, Stephen Stahl, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trialStephen M Stahl, Maurizio Fava, Madhukar H Trivedi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2007
Clinical response by palpation during primary systemic therapy with four dose-dense cycles doxorubicin and docetaxel in patients with operable breast cancer: further results from a randomised controlled trialChristine Müller, Angelika Caputo, Martin Schumacher, et al.
Current Alzheimer Research|October 9, 2020
Modelling Decline in Cognition to Decline in Function in Alzheimer's DiseaseHelene Karcher, Marina Savelieva, Luyuan Qi, et al.
Alzheimer'S Research & Therapy|April 29, 2015
Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's diseaseMartin R Farlow, Niels Andreasen, Marie-Emmanuelle Riviere, et al.
Dementia and Geriatric Cognitive Disorders|July 17, 2012
Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's diseaseJeffrey Cummings, Lutz Froelich, Sandra E Black, et al.
Journal of the American College of Cardiology|November 7, 2006
Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placementWillibald Hochholzer, Dietmar Trenk, Hans-Peter Bestehorn, et al.
Pageof 2